Irhythm Technologies 控股公司达成一项交易，市场普遍预期此举将从2027年开始显著提振其营收增长率。与此同时，公司管理层重申，2027年经调整后的息税折旧摊销前利润率（Adj Ebitda Margin）目标仍将维持在15%的水平。这一战略布局，旨在强化公司未来的财务表现，为长期增长注入新动能。
Irhythm Technologies 控股公司达成一项交易，市场普遍预期此举将从2027年开始显著提振其营收增长率。与此同时，公司管理层重申，2027年经调整后的息税折旧摊销前利润率（Adj Ebitda Margin）目标仍将维持在15%的水平。这一战略布局，旨在强化公司未来的财务表现，为长期增长注入新动能。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.